PATH
@malariavaccine.org
PATH’s decades of work on malaria spans the entire vaccine development and delivery spectrum. From our diverse research and development portfolio to our dedication to ensuring access to malaria vaccines in Africa, we’re working with partners to usher in a new era of malaria prevention.
PATH's Company Logos
PATH's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#933030
Stiletto
147, 48, 48
0, 51, 38
0, 67, 67, 42
#70A6DB
Danube
112, 166, 219
210, 60, 65
49, 24, 0, 14
#010101
Black
1, 1, 1
0, 0, 0
0, 0, 0, 100
About PATH
The Malaria Vaccine Initiative (MVI) is a program of PATH, an international nonprofit organization dedicated to saving lives and improving health, especially among women and children. MVI collaborates with partners in private industry, government, and academia to develop effective malaria vaccines. Their key activities include establishing partnerships for manufacturing and producing vaccine candidates, managing intellectual property issues, conducting clinical trials, and developing innovative evaluation technologies.
MVI also advocates for increased global spending on malaria research and development. As part of PATH's global team, MVI works towards accelerating health equity and addressing complex health challenges, such as malaria. They are led by a dedicated team of experts who strive to make a positive impact on global health.
Contact information for MVI is available on the PATH website
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
